Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis

Treatment options for metastatic renal cell carcinoma (RCC) are limited. In this study, we investigated impact of prostaglandin E2 (PGE2) receptor 4 (EP4) on RCC metastasis. We found that knockdown of EP4 in two RCC cell lines, ACHN and SN12C, does not affect xenograft tumor take or growth rate in m...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Lett
Main Authors: Zhang, Yushan, Purayil, Hamsa Thayele, Black, Joseph B., Fetto, Francis, Lynch, Lauren D., Masannat, Jude N., Daaka, Yehia
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5340307/
https://ncbi.nlm.nih.gov/pubmed/28104442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.01.007
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items